Burcu Aslan

Postdoctoral Fellow

  • Phone713-792-3508
  • 240 Citations
  • 9 h-Index
20132019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
Exosomes Medicine & Life Sciences
Elongation Factor 2 Kinase Medicine & Life Sciences
Carcinogenesis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 240 Citations
  • 9 h-Index
  • 10 Article
  • 2 Chapter
  • 1 Review article

Ex Vivo Pharmacological Profiling in Chronic Lymphocytic Leukemia Cells

Aslan, B., Ayres, M. L. & Gandhi, V. V., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 19-25 7 p. (Methods in Molecular Biology; vol. 1881).

Research output: Chapter in Book/Report/Conference proceedingChapter

B-Cell Chronic Lymphocytic Leukemia
Pharmacology
Pharmaceutical Preparations
Drug Combinations
Lymphocytes

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

Rodriguez-Aguayo, C., Bayraktar, E., Ivan, C., Aslan, B., Mai, J., He, G., Mangala, L. S., Jiang, D., Nagaraja, A. S., Ozpolat, B., Chavez-Reyes, A., Ferrari, M., Mitra, R., Siddik, Z. H., Shen, H., Yang, X., Sood, A. K. & Lopez, G., Feb 1 2019, In : EBioMedicine. 40, p. 290-304 15 p.

Research output: Contribution to journalArticle

Dinoprostone
Cisplatin
Ovary
Carcinogenesis
Up-Regulation

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer

Kanlikilicer, P., Bayraktar, R., Denizli, M., Rashed, M. H., Ivan, C., Aslan, B., Mitra, R., Karagoz, K., Bayraktar, E., Zhang, X., Rodriguez-Aguayo, C., El-Arabey, A. A., Kahraman, N., Baydogan, S., Ozkayar, O., Gatza, M. L., Ozpolat, B., Calin, G. A., Sood, A. K. & Lopez, G., Dec 1 2018, In : EBioMedicine. 38, p. 100-112 13 p.

Research output: Contribution to journalArticle

Macrophages
MicroRNAs
Ovarian Neoplasms
Paclitaxel
Tumors

Chitosan nanoparticles for miRNA delivery

Denizli, M., Aslan, B., Mangala, L. S., Jiang, D., Rodriguez-Aguayo, C., Lopez, G. & Sood, A. K., Jan 1 2017, Methods in Molecular Biology. Humana Press Inc., p. 219-230 12 p. (Methods in Molecular Biology; vol. 1632).

Research output: Chapter in Book/Report/Conference proceedingChapter

Chitosan
MicroRNAs
Nanoparticles
RNA Interference
Intravenous Administration
15 Citations (Scopus)

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: A possible role for exosomal disposal of tumor suppressor miRNAs

Rashed, M. H., Kanlikilicer, P., Rodriguez-Aguayo, C., Pichler, M., Bayraktar, R., Bayraktar, E., Ivan, C., Filant, J., Silva, A., Aslan, B., Denizli, M., Mitra, R., Ozpolat, B., Calin, G. A., Sood, A. K., Abd-Ellah, M. F., Helal, G. K. & Lopez, G., Jan 1 2017, In : Oncotarget. 8, 12, p. 20145-20164 20 p.

Research output: Contribution to journalArticle

MicroRNAs
Exosomes
Ovarian Neoplasms
Neoplasms
Proto-Oncogene Proteins